RPG Investment Advisory LLC Decreases Holdings in SPDR S&P Biotech ETF (XBI)

RPG Investment Advisory LLC lowered its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.5% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 19,906 shares of the exchange traded fund’s stock after selling 500 shares during the period. RPG Investment Advisory LLC’s holdings in SPDR S&P Biotech ETF were worth $1,802,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Gradient Investments LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 1st quarter valued at $27,000. Cranbrook Wealth Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at $26,000. Quattro Financial Advisors LLC boosted its stake in shares of SPDR S&P Biotech ETF by 49.6% during the 4th quarter. Quattro Financial Advisors LLC now owns 374 shares of the exchange traded fund’s stock valued at $31,000 after buying an additional 124 shares during the period. Truewealth LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at $29,000. Finally, Lehman & Derafelo Financial Resources LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at $32,000.

Shares of NYSEARCA:XBI traded down $0.80 during trading on Monday, reaching $89.10. 3,828,432 shares of the company traded hands, compared to its average volume of 4,755,300. SPDR S&P Biotech ETF has a 1-year low of $64.38 and a 1-year high of $101.55.

ILLEGAL ACTIVITY NOTICE: “RPG Investment Advisory LLC Decreases Holdings in SPDR S&P Biotech ETF (XBI)” was published by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this piece on another publication, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this piece can be accessed at https://transcriptdaily.com/2019/04/16/rpg-investment-advisory-llc-decreases-holdings-in-spdr-sp-biotech-etf-xbi.html.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Further Reading: What is Call Option Volume?

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.